[1] Liver damage results not from paracetamol itself, but from one of its metabolites, N -acetyl- p -benzoquinone imine (NAPQI)
Ozempic shortages have been ongoing because people without diabetes were using it off-label for weight loss, pulling supply away from diabetic patients
announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
2011), facilitating the incorporation of C12:0 into the glycerol backbone
[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Pratley RE, Nauck M, Bailey T, et al
control, 291) (standardised mean difference: 039